Do analysts prefer PLRZ or AIFC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Polyrizon 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 ALT5 Sigma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, PLRZ or AIFC?

Polyrizon has higher earnings, but lower revenue than ALT5 Sigma. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Polyrizon N/A N/A -$3.34M N/A N/A ALT5 Sigma $24.84M 3.73 -$344.51M N/A N/A

Is PLRZ or AIFC more profitable?

Polyrizon has a net margin of 0.00% compared to ALT5 Sigma's net margin of -2,483.94%. Polyrizon's return on equity of 0.00% beat ALT5 Sigma's return on equity. Company Net Margins Return on Equity Return on Assets Polyrizon N/A N/A N/A ALT5 Sigma -2,483.94% -68.25% -62.43%

Do analysts prefer PLRZ or FTLF?

FitLife Brands has a consensus target price of $21.50, suggesting a potential upside of 104.76%. Given FitLife Brands' stronger consensus rating and higher probable upside, analysts plainly believe FitLife Brands is more favorable than Polyrizon. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Polyrizon 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 FitLife Brands 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has preferable valuation and earnings, PLRZ or FTLF?

FitLife Brands has higher revenue and earnings than Polyrizon. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Polyrizon N/A N/A -$3.34M N/A N/A FitLife Brands $81.46M 1.21 $6.33M $0.60 17.50

Does the media favor PLRZ or FTLF?

In the previous week, Polyrizon had 3 more articles in the media than FitLife Brands. MarketBeat recorded 6 mentions for Polyrizon and 3 mentions for FitLife Brands. Polyrizon's average media sentiment score of 0.66 beat FitLife Brands' score of -0.53 indicating that Polyrizon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Polyrizon 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive FitLife Brands 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative

Do analysts prefer PLRZ or ETHZ?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Polyrizon 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Flag Ship Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, PLRZ or ETHZ?

Polyrizon has higher earnings, but lower revenue than Flag Ship Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Polyrizon N/A N/A -$3.34M N/A N/A Flag Ship Acquisition $4.11M 24.56 -$6.17M -$159.65 N/A

Is PLRZ or ETHZ more profitable?

Polyrizon's return on equity of 0.00% beat Flag Ship Acquisition's return on equity. Company Net Margins Return on Equity Return on Assets Polyrizon N/A N/A N/A Flag Ship Acquisition N/A -185.71% -83.12%

Does the media refer more to PLRZ or ETHZ?

In the previous week, Polyrizon had 5 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 6 mentions for Polyrizon and 1 mentions for Flag Ship Acquisition. Flag Ship Acquisition's average media sentiment score of 0.75 beat Polyrizon's score of 0.66 indicating that Flag Ship Acquisition is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Polyrizon 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Flag Ship Acquisition 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, ATRA or PLRZ?

Atara Biotherapeutics has higher revenue and earnings than Polyrizon. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Atara Biotherapeutics $120.77M 0.74 $32.69M -$0.67 N/A Polyrizon N/A N/A -$3.34M N/A N/A

Do analysts rate THAR or PLRZ?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tharimmune 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Polyrizon 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, THAR or PLRZ?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tharimmune N/A N/A -$12.20M -$3.99 N/A Polyrizon N/A N/A -$3.34M N/A N/A

Is THAR or PLRZ more profitable?

Polyrizon's return on equity of 0.00% beat Tharimmune's return on equity. Company Net Margins Return on Equity Return on Assets Tharimmune N/A -588.45% -264.41% Polyrizon N/A N/A N/A

Polyrizon (PLRZ) Competitors

$12.88 +0.36 (+2.87%)

As of 11:01 AM Eastern

Compare

PLRZ vs. AIFC, FTLF, ETHZ, ATRA, and THAR

Should you buy Polyrizon stock or one of its competitors? MarketBeat compares Polyrizon with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Polyrizon include ALT5 Sigma (AIFC), FitLife Brands (FTLF), Flag Ship Acquisition (ETHZ), Atara Biotherapeutics (ATRA), and Tharimmune (THAR). These companies are all part of the "pharmaceutical products" industry.

How does Polyrizon compare to ALT5 Sigma?

Polyrizon (NASDAQ:PLRZ) and ALT5 Sigma (NASDAQ:AIFC) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, Polyrizon had 6 more articles in the media than ALT5 Sigma. MarketBeat recorded 6 mentions for Polyrizon and 0 mentions for ALT5 Sigma. Polyrizon's average media sentiment score of 0.66 beat ALT5 Sigma's score of 0.00 indicating that Polyrizon is being referred to more favorably in the media.

Company	Overall Sentiment
Polyrizon	Positive
ALT5 Sigma	Neutral

6.3% of ALT5 Sigma shares are held by institutional investors. 0.2% of ALT5 Sigma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Polyrizon	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
ALT5 Sigma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Polyrizon has a net margin of 0.00% compared to ALT5 Sigma's net margin of -2,483.94%. Polyrizon's return on equity of 0.00% beat ALT5 Sigma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Polyrizon	N/A	N/A	N/A
ALT5 Sigma	-2,483.94%	-68.25%	-62.43%

Polyrizon has higher earnings, but lower revenue than ALT5 Sigma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Polyrizon	N/A	N/A	-$3.34M	N/A	N/A
ALT5 Sigma	$24.84M	3.73	-$344.51M	N/A	N/A

Polyrizon has a beta of -1.91, indicating that its share price is 291% less volatile than the broader market. Comparatively, ALT5 Sigma has a beta of 1.71, indicating that its share price is 71% more volatile than the broader market.

Summary

Polyrizon beats ALT5 Sigma on 6 of the 10 factors compared between the two stocks.

How does Polyrizon compare to FitLife Brands?

Polyrizon (NASDAQ:PLRZ) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

FitLife Brands has a consensus target price of $21.50, suggesting a potential upside of 104.76%. Given FitLife Brands' stronger consensus rating and higher probable upside, analysts plainly believe FitLife Brands is more favorable than Polyrizon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Polyrizon	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Polyrizon had 3 more articles in the media than FitLife Brands. MarketBeat recorded 6 mentions for Polyrizon and 3 mentions for FitLife Brands. Polyrizon's average media sentiment score of 0.66 beat FitLife Brands' score of -0.53 indicating that Polyrizon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Polyrizon	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
FitLife Brands	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative

FitLife Brands has higher revenue and earnings than Polyrizon.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Polyrizon	N/A	N/A	-$3.34M	N/A	N/A
FitLife Brands	$81.46M	1.21	$6.33M	$0.60	17.50

Polyrizon has a beta of -1.91, suggesting that its stock price is 291% less volatile than the broader market. Comparatively, FitLife Brands has a beta of 0.02, suggesting that its stock price is 98% less volatile than the broader market.

FitLife Brands has a net margin of 6.64% compared to Polyrizon's net margin of 0.00%. FitLife Brands' return on equity of 18.31% beat Polyrizon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Polyrizon	N/A	N/A	N/A
FitLife Brands	6.64%	18.31%	8.21%

2.3% of FitLife Brands shares are owned by institutional investors. 61.4% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

FitLife Brands beats Polyrizon on 11 of the 13 factors compared between the two stocks.

How does Polyrizon compare to Flag Ship Acquisition?

Polyrizon (NASDAQ:PLRZ) and Flag Ship Acquisition (NASDAQ:ETHZ) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

In the previous week, Polyrizon had 5 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 6 mentions for Polyrizon and 1 mentions for Flag Ship Acquisition. Flag Ship Acquisition's average media sentiment score of 0.75 beat Polyrizon's score of 0.66 indicating that Flag Ship Acquisition is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Polyrizon	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Flag Ship Acquisition	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

4.1% of Flag Ship Acquisition shares are owned by institutional investors. 15.1% of Flag Ship Acquisition shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Polyrizon has higher earnings, but lower revenue than Flag Ship Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Polyrizon	N/A	N/A	-$3.34M	N/A	N/A
Flag Ship Acquisition	$4.11M	24.56	-$6.17M	-$159.65	N/A

Polyrizon's return on equity of 0.00% beat Flag Ship Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Polyrizon	N/A	N/A	N/A
Flag Ship Acquisition	N/A	-185.71%	-83.12%

Polyrizon has a beta of -1.91, meaning that its share price is 291% less volatile than the broader market. Comparatively, Flag Ship Acquisition has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Polyrizon	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Flag Ship Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Flag Ship Acquisition beats Polyrizon on 5 of the 9 factors compared between the two stocks.

How does Polyrizon compare to Atara Biotherapeutics?

Atara Biotherapeutics (NASDAQ:ATRA) and Polyrizon (NASDAQ:PLRZ) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

In the previous week, Polyrizon had 6 more articles in the media than Atara Biotherapeutics. MarketBeat recorded 6 mentions for Polyrizon and 0 mentions for Atara Biotherapeutics. Polyrizon's average media sentiment score of 0.66 beat Atara Biotherapeutics' score of 0.00 indicating that Polyrizon is being referred to more favorably in the news media.

Company	Overall Sentiment
Atara Biotherapeutics	Neutral
Polyrizon	Positive

70.9% of Atara Biotherapeutics shares are owned by institutional investors. 41.2% of Atara Biotherapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Atara Biotherapeutics currently has a consensus price target of $9.50, suggesting a potential downside of 4.23%. Given Atara Biotherapeutics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Atara Biotherapeutics is more favorable than Polyrizon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Atara Biotherapeutics	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Polyrizon	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Polyrizon has a net margin of 0.00% compared to Atara Biotherapeutics' net margin of -40.91%. Polyrizon's return on equity of 0.00% beat Atara Biotherapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Atara Biotherapeutics	-40.91%	-79.12%	-35.29%
Polyrizon	N/A	N/A	N/A

Atara Biotherapeutics has a beta of 0.1, meaning that its stock price is 90% less volatile than the broader market. Comparatively, Polyrizon has a beta of -1.91, meaning that its stock price is 291% less volatile than the broader market.

Atara Biotherapeutics has higher revenue and earnings than Polyrizon.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atara Biotherapeutics	$120.77M	0.74	$32.69M	-$0.67	N/A
Polyrizon	N/A	N/A	-$3.34M	N/A	N/A

Summary

Atara Biotherapeutics beats Polyrizon on 8 of the 13 factors compared between the two stocks.

How does Polyrizon compare to Tharimmune?

Tharimmune (NASDAQ:THAR) and Polyrizon (NASDAQ:PLRZ) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tharimmune	N/A	N/A	-$12.20M	-$3.99	N/A
Polyrizon	N/A	N/A	-$3.34M	N/A	N/A

In the previous week, Polyrizon had 6 more articles in the media than Tharimmune. MarketBeat recorded 6 mentions for Polyrizon and 0 mentions for Tharimmune. Polyrizon's average media sentiment score of 0.66 beat Tharimmune's score of 0.00 indicating that Polyrizon is being referred to more favorably in the news media.

Company	Overall Sentiment
Tharimmune	Neutral
Polyrizon	Positive

Tharimmune has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market. Comparatively, Polyrizon has a beta of -1.91, suggesting that its stock price is 291% less volatile than the broader market.

1.2% of Tharimmune shares are held by institutional investors. 6.7% of Tharimmune shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Polyrizon's return on equity of 0.00% beat Tharimmune's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tharimmune	N/A	-588.45%	-264.41%
Polyrizon	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tharimmune	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Polyrizon	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Polyrizon beats Tharimmune on 5 of the 8 factors compared between the two stocks.

Get Polyrizon News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PLRZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PLRZ vs. The Competition

Export

Metric	Polyrizon	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$24.08M	$3.31B	$6.46B	$11.95B
Dividend Yield	N/A	2.31%	2.67%	5.58%
P/E Ratio	N/A	19.05	23.94	23.78
Price / Sales	N/A	305.18	531.66	117.30
Price / Cash	N/A	51.45	26.99	37.25
Price / Book	0.99	8.09	10.55	6.76
Net Income	-$3.34M	$23.89M	$3.56B	$337.14M
7 Day Performance	-8.59%	-3.06%	-0.93%	-1.75%
1 Month Performance	-21.18%	2.84%	1.58%	2.32%
1 Year Performance	156.33%	36.43%	20.99%	25.63%

Polyrizon Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PLRZ Polyrizon	1.0726 of 5 stars	$12.88 +2.9%	N/A	+159.5%	$24.08M	N/A	N/A	N/A	News Coverage Analyst Upgrade
AIFC ALT5 Sigma	0.1089 of 5 stars	$0.67 -7.2%	N/A	-93.6%	$93.13M	$24.70M	N/A	170
FTLF FitLife Brands	4.3015 of 5 stars	$9.91 -0.4%	$21.50 +117.1%	-27.5%	$93.02M	$90.85M	16.40	20
ETHZ Flag Ship Acquisition	0.1915 of 5 stars	$4.87 +2.1%	N/A	N/A	$92.59M	$4.11M	N/A	7
ATRA Atara Biotherapeutics	0.6526 of 5 stars	$10.09 -1.8%	$9.50 -5.8%	+3.8%	$90.91M	$120.77M	N/A	330	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PLRZ) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Polyrizon (PLRZ) Competitors

PLRZ vs. AIFC, FTLF, ETHZ, ATRA, and THAR

How does Polyrizon compare to ALT5 Sigma?

Summary

How does Polyrizon compare to FitLife Brands?

Summary

How does Polyrizon compare to Flag Ship Acquisition?

Summary

How does Polyrizon compare to Atara Biotherapeutics?

Summary

How does Polyrizon compare to Tharimmune?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PLRZ vs. The Competition

Polyrizon Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Polyrizon (PLRZ) Competitors

PLRZ vs. AIFC, FTLF, ETHZ, ATRA, and THAR

How does Polyrizon compare to ALT5 Sigma?

Does the media prefer PLRZ or AIFC?

Do insiders & institutionals believe in PLRZ or AIFC?

Do analysts prefer PLRZ or AIFC?

Is PLRZ or AIFC more profitable?

Which has better earnings & valuation, PLRZ or AIFC?

Which has more volatility and risk, PLRZ or AIFC?

Summary

How does Polyrizon compare to FitLife Brands?

Do analysts prefer PLRZ or FTLF?

Does the media favor PLRZ or FTLF?

Which has preferable valuation and earnings, PLRZ or FTLF?

Which has more volatility & risk, PLRZ or FTLF?

Is PLRZ or FTLF more profitable?

Do institutionals & insiders hold more shares of PLRZ or FTLF?

Summary

How does Polyrizon compare to Flag Ship Acquisition?

Does the media refer more to PLRZ or ETHZ?

Do institutionals and insiders believe in PLRZ or ETHZ?

Which has higher earnings and valuation, PLRZ or ETHZ?

Is PLRZ or ETHZ more profitable?

Which has more volatility and risk, PLRZ or ETHZ?

Do analysts prefer PLRZ or ETHZ?

Summary

How does Polyrizon compare to Atara Biotherapeutics?

Does the media prefer ATRA or PLRZ?

Do insiders & institutionals hold more shares of ATRA or PLRZ?

Do analysts recommend ATRA or PLRZ?

Is ATRA or PLRZ more profitable?

Which has more volatility and risk, ATRA or PLRZ?

Which has better earnings & valuation, ATRA or PLRZ?

Summary

How does Polyrizon compare to Tharimmune?

Which has preferable earnings & valuation, THAR or PLRZ?

Does the media favor THAR or PLRZ?

Which has more risk and volatility, THAR or PLRZ?

Do institutionals and insiders hold more shares of THAR or PLRZ?

Is THAR or PLRZ more profitable?

Do analysts rate THAR or PLRZ?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PLRZ vs. The Competition

Polyrizon Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools